Skip to main content

Institutional Review Board (IRB)

  • Chapter
  • First Online:
Book cover Developing a Successful Clinical Research Program
  • 697 Accesses

Abstract

The IRB application collects a lot of information specific to clinical research trials in general. There are different types of scientific design, including randomized controlled trials (or RCTs), retrospective review of data that has already been collected, and prospective registries, which is an observational only trial. Some clinical research endeavors may be exempt from IRB review, some studies able to undergo expedited review, but must will go through a full board review. There are four phases of human clinical research: phase I dose finding (20–100 subjects), phase II assessing safety and efficacy (100–300 subjects), phase III firmly establishing safety and efficacy (300–3000 subjects), and phase IV post marketing for further information. There are some high-risk procedures (such as those involving radiation therapy or viruses that require special approvals.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 64.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 84.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Food & Drug Administration. Categories of research that may be reviewed by the IRB through an expedited review procedure. Nov 9, 1998. https://www.fda.gov/ScienceResearch/SpecialTopics/RunningClinicalTrials/ucm 119074.htm.

  2. Food & Drug Administration. Code of federal regulations: title 21, part 56 institutional review boards. 2017. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=56.107.

  3. Food & Drug Administration. The drug development process: step 3 clinical research. 2018. https:www.fda.gov/ForPatients/Approvals/Drugs/default.htm.

  4. Office for Human Research Protections. The Belmont report: ethical principles and guidelines for the protection of human subjects of research. 1979. https://www.hhs.gov/ohrp/regulations-and-policy/belmont-report/read-the-belmont-report/index.html.

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

East, C. (2018). Institutional Review Board (IRB). In: Developing a Successful Clinical Research Program. Springer, Cham. https://doi.org/10.1007/978-3-319-54693-3_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-54693-3_9

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-54692-6

  • Online ISBN: 978-3-319-54693-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics